SoftBank Builds a $5 Billion Stake in Pharma Giant Roche
Japanese firm’s stake makes it one of Roche’s top investors
SoftBank believes Roche’s Genentech division is undervalued
WATCH: SoftBank Group Corp. has built a $5 billion stake in Roche Holding AG, placing a big bet on the pharma giant’s strategy of using data to develop drugs. (Source: Bloomberg)
SoftBank Group Corp. has quietly built a $5 billion stake in Roche Holding AG, placing a bet on the pharmaceutical company’s strategy of using data to develop drugs, according to people familiar with the matter.
The Japanese conglomerate is now one of Roche’s largest investors, according to data compiled by Bloomberg.
